These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15671153)

  • 1. Repetitive postprandial hyperglycemia increases cardiac ischemia/reperfusion injury: prevention by the alpha-glucosidase inhibitor acarbose.
    Frantz S; Calvillo L; Tillmanns J; Elbing I; Dienesch C; Bischoff H; Ertl G; Bauersachs J
    FASEB J; 2005 Apr; 19(6):591-3. PubMed ID: 15671153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
    Yamagishi S; Nakamura K; Takeuchi M
    Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acarbose reduces myocardial infarct size by preventing postprandial hyperglycemia and hydroxyl radical production and opening mitochondrial KATP channels in rabbits.
    Minatoguchi S; Zhang Z; Bao N; Kobayashi H; Yasuda S; Iwasa M; Sumi S; Kawamura I; Yamada Y; Nishigaki K; Takemura G; Fujiwara T; Fujiwara H
    J Cardiovasc Pharmacol; 2009 Jul; 54(1):25-30. PubMed ID: 19487955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lowering postprandial hyperglycemia on insulin secretion in older people with impaired glucose tolerance.
    Chang AM; Smith MJ; Bloem CJ; Galecki AT; Halter JB
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E906-11. PubMed ID: 15213063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the alpha glucosidase inhibitor acarbose on endothelial function after a mixed meal in newly diagnosed type 2 diabetes.
    Pistrosch F; Schaper F; Passauer J; Koehler C; Bornstein SR; Hanefeld M
    Horm Metab Res; 2009 Feb; 41(2):104-8. PubMed ID: 19061152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of acarbose, alpha-glucosidase inhibitor in treatment of impaired glucose tolerance].
    Sakamoto N; Tajima N
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():451-6. PubMed ID: 15779421
    [No Abstract]   [Full Text] [Related]  

  • 7. Acarbose, an alpha-glucosidase inhibitor, improves endothelial dysfunction in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation.
    Azuma K; Toyofuku Y; Iesaki T; Otsuka A; Tanaka A; Mita T; Hirose T; Tanaka Y; Daida H; Kawamori R; Watada H
    Biochem Biophys Res Commun; 2006 Jun; 345(2):688-93. PubMed ID: 16696939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-insulin-dependent diabetes mellitus associated with nonalcoholic liver cirrhosis: an evaluation of treatment with the intestinal alpha-glucosidase inhibitor acarbose].
    Gentile S; Turco S; Guarino G; Oliviero B; Rustici A; Torella R
    Ann Ital Med Int; 1999; 14(1):7-14. PubMed ID: 10528419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice.
    Montecucco F; Lenglet S; Braunersreuther V; Pelli G; Pellieux C; Montessuit C; Lerch R; Deruaz M; Proudfoot AE; Mach F
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1371-7. PubMed ID: 20413731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acarbose is a promising therapeutic strategy for the treatment of patients with nonalcoholic steatohepatitis (NASH).
    Yamagishi S; Nakamura K; Inoue H
    Med Hypotheses; 2005; 65(2):377-9. PubMed ID: 15922116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of myocardial ischemia-reperfusion injury by inhibitors of cytochrome P450 in rats.
    Ishihara Y; Sekine M; Nakazawa M; Shimamoto N
    Eur J Pharmacol; 2009 Jun; 611(1-3):64-71. PubMed ID: 19356728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of alpha-glucosidase inhibition in the management of diabetes.
    Bischoff H
    Clin Invest Med; 1995 Aug; 18(4):303-11. PubMed ID: 8549017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients.
    Seifarth C; Bergmann J; Holst JJ; Ritzel R; Schmiegel W; Nauck MA
    Diabet Med; 1998 Jun; 15(6):485-91. PubMed ID: 9632123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alpha (α)-glucosidase inhibitor, acarbose, attenuates the blood pressure and splanchnic blood flow responses to intraduodenal sucrose in older adults.
    Gentilcore D; Vanis L; Wishart JM; Rayner CK; Horowitz M; Jones KL
    J Gerontol A Biol Sci Med Sci; 2011 Aug; 66(8):917-24. PubMed ID: 21628676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acarbose, an alpha-glucosidase inhibitor, improves insulin resistance in fructose-fed rats.
    Nakamura K; Yamagishi S; Matsui T; Inoue H
    Drugs Exp Clin Res; 2005; 31(4):155-9. PubMed ID: 16223205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The eNOS enhancer AVE 9488: a novel cardioprotectant against ischemia reperfusion injury.
    Frantz S; Adamek A; Fraccarollo D; Tillmanns J; Widder JD; Dienesch C; Schäfer A; Podolskaya A; Held M; Ruetten H; Ertl G; Bauersachs J
    Basic Res Cardiol; 2009 Nov; 104(6):773-9. PubMed ID: 19548059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effect of alpha-glucosidase inhibitor on late dumping syndrome.
    Hasegawa T; Yoneda M; Nakamura K; Ohnishi K; Harada H; Kyouda T; Yoshida Y; Makino I
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1201-6. PubMed ID: 9918426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acarbose reduces blood pressure in sucrose-induced hypertension in rats.
    Madar Z; Melamed EC; Zimlichman R
    Isr J Med Sci; 1997 Mar; 33(3):153-9. PubMed ID: 9313782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of inhibition of alpha-glucosidase on age-related glucose intolerance and pancreatic atrophy in rats.
    Yamamoto M; Otsuki M
    Metabolism; 2006 Apr; 55(4):533-40. PubMed ID: 16546485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hyperglycemia exacerbates myocardial ischemia/reperfusion injury and blunts cardioprotective effect of GIK.
    Su H; Sun X; Ma H; Zhang HF; Yu QJ; Huang C; Wang XM; Luan RH; Jia GL; Wang HC; Gao F
    Am J Physiol Endocrinol Metab; 2007 Sep; 293(3):E629-35. PubMed ID: 17519283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.